APPLICATION
ANDA207400
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-14
LATEST ACTION
2020-11-12
ROUTE
INTRAVENOUS, INTRAMUSCULAR
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
CAFFEINE CITRATEPrescription
CAFFEINE CITRATE EQ 30MG BASE/3ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2020-11-12Labeling · Supplement 4 · standardAP
2020-11-12Labeling · Supplement 5 · standardAP
2020-11-12Labeling · Supplement 3 · standardAP
2017-12-14UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.